Biogen Idec's CEO To Retire
Friday, January 8, 2010 - 10:14
in Mathematics & Economics
Biotechnology: James Mullen will leave as the company grapples with a stagnant pipeline.
Biotechnology: James Mullen will leave as the company grapples with a stagnant pipeline.